Skip to content

Liposomal bupivacaine for anterior quadratus lumborum block at the lateral supra-arcuate ligament in the analgesic effect after laparoscopic nephrectomy

Analgesic effect of liposomal bupivacaine for quadratus lumbar block after laparoscopic nephrectomy: a prospective, double-blind, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094955
Enrollment
Unknown
Registered
2024-12-31
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic nephrectomy

Interventions

Liposomal Bupivacaine Group:Before induction, 10 ml of liposomal bupivacaine (133mg) mixed with 10 ml of normal saline is used to perform a quadratus lumborum block on the surgical side.
Bupivacaine Hydrochloride Group:Before induction, 20 ml of 0.375% bupivacaine hydrochloride is used to perform a quadratus lumborum block on the surgical side.

Sponsors

The Affiliated Hospital of Xuzhou Medical University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. 20 years old < age < 75 years old; 2. Body Mass Index (BMI): 20-30 kg/m^2; 3. American Society of Anesthesiologists (ASA) physical status classification: I-III; 4. Patients undergoing elective laparoscopic nephrectomy.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to regional block: coagulation disorders, infection at the puncture site, allergy to local anesthetics, etc.; 2. Long-term use of opioids or any analgesics for 3 months or more, history of chronic pain; 3. Allergy to medications used in the standardized anesthesia protocol; 4. Local or systemic infection; 5. Inability to use the PCA (Patient-Controlled Analgesia) system and pregnant patients; 6. History of neurological or psychiatric disorders, long-term use of sedative medications; 7. Inability to cooperate with the study for any reason: hearing impairment, language comprehension difficulties, not understanding the use of NRS (Numerical Rating Scale), refusal to participate.

Design outcomes

Primary

MeasureTime frame
Total morphine equivalent consumption within 48 hours postoperatively.;

Secondary

MeasureTime frame
Postoperative Quality of Recovery-15 (QoR-15) scores at 24 and 48 hours.;Numerical Rating Scale (NRS) pain scores ;The time of the first analgesic pump press postoperatively.;Incidence of rescue analgesia and dosage of rescue analgesic medication.;Incidence of postoperative nausea and vomiting.;Patient satisfaction;Sensory block level assessment 15 , 30 minutes after nerve block;Incidence of local anaesthetic poisoning;Surgical duration and intraoperative remifentanil consumption;Postoperative Athens Insomnia Scale (AIS) scores;The time of the first time getting out of bed after surgery.;PACU(Post-Anesthesia Care Unit) Stay Duration;Incidence of pruritus;Incidence of numbness in the blocked area;Other adverse reactions and the occurrence of complications;

Countries

China

Contacts

Public ContactMengxing Jia

The Department of Anesthesiology at Xuzhou Medical University Affiliated Hospital

xzmu_jiamengxing@126.com+86 158 9523 8016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026